What is the appropriate dosing and titration of nicardipine (Cardene) intravenous infusion in a patient with end‑stage renal disease?

Nicardipine Dosing in End-Stage Renal Disease

Nicardipine can be used at standard doses in patients with end-stage renal disease (ESRD) without dose adjustment, but requires slower titration and more cautious blood-pressure reduction targets to prevent hypotension and organ hypoperfusion. 1, 2

Standard Dosing Protocol Applies to ESRD

• Start nicardipine at 5 mg/hr IV infusion through a central line or large peripheral vein, regardless of renal function. 2, 3
• Titrate by 2.5 mg/hr every 5–15 minutes (use 15-minute intervals for gradual titration in ESRD) up to a maximum of 15 mg/hr until the desired blood-pressure reduction is achieved. 2, 4, 3
• No dose reduction is required for patients with ESRD or severe renal impairment (CrCl <15 mL/min), though the European Heart Journal notes that systemic clearance is lower and drug exposure (AUC) is higher in moderate renal impairment. 4

Critical Titration Modifications for ESRD

• Use the slower 15-minute titration interval rather than 5-minute rapid titration to allow adequate time to assess blood-pressure response and avoid precipitous drops. 2, 3
• Begin at the lower end of the dosing range (5 mg/hr) and increase cautiously, as patients with ESRD often have impaired autoregulation and are more vulnerable to hypotension-related organ ischemia. 1
• Aim for a conservative 10–15% reduction in mean arterial pressure within the first hour, not exceeding 25% reduction in the first 24 hours. 1, 2

Blood-Pressure Monitoring Requirements

• Monitor blood pressure every 15 minutes during active titration, then every 30 minutes once stable, and hourly thereafter. 2, 4
• Continuously monitor heart rate, as nicardipine may cause reflex tachycardia (approximately 10 bpm increase). 5
• If hypotension or excessive tachycardia develops, stop the infusion immediately; once hemodynamics stabilize, restart at 3–5 mg/hr and titrate more slowly. 2, 3

Renal-Specific Considerations

• Nicardipine is a preferred agent for hypertensive emergencies in acute renal failure because it does not compromise renal perfusion and may even dilate the renal artery, increasing glomerular filtration rate. 1, 6
• In patients undergoing deliberate hypotension during surgery, nicardipine increased creatinine clearance and attenuated the rise in fractional excretion of sodium, suggesting a renal-protective effect. 6
• Preserve peripheral veins in patients with stage III–V chronic kidney disease who may require future hemodialysis access; use a central line or large peripheral vein and change the infusion site every 12 hours to minimize phlebitis. 3, 7

Maintenance and Transition to Oral Therapy

• Once the blood-pressure goal is achieved, reduce the infusion to 3 mg/hr for maintenance. 2, 3
• The offset of action occurs within 30–40 minutes after discontinuation, regardless of infusion duration. 4, 5
• If transitioning to oral antihypertensives other than nicardipine, initiate the oral agent upon stopping the IV infusion; if using oral nicardipine, administer the first dose 1 hour before discontinuing the IV infusion. 3

Common Pitfalls to Avoid in ESRD

• Do not use rapid 5-minute titration intervals in ESRD patients, as impaired autoregulation increases the risk of cerebral, renal, or coronary ischemia from abrupt blood-pressure drops. 1, 2
• Do not exceed a 25% reduction in blood pressure within the first 24 hours, as excessive reduction can precipitate stroke, myocardial infarction, or acute kidney injury. 1, 2
• Do not assume nicardipine requires dose reduction in ESRD; the standard maximum dose of 15 mg/hr applies, but slower titration is essential. 2, 4
• Do not use small peripheral veins (e.g., dorsum of hand or wrist), as nicardipine can cause phlebitis, especially after 14 hours of infusion at a single site. 3, 5

Special Populations and Drug Interactions

• In patients receiving cyclosporine or tacrolimus, monitor immunosuppressant levels closely, as nicardipine inhibits CYP3A4 and can significantly elevate these levels. 4
• Elderly patients do not require dose adjustment when using nicardipine. 4
• Titrate slowly in patients with heart failure or impaired hepatic function in addition to renal impairment. 3